Skip to main content
No.1 Press Release Service in Korea
Search
Search
Login
Create Account
Services
Contact Us
News
Services
About Us
Contact Us
Korean
News
All News
News by Region
Korea
Overseas
News by Industry
Health
Economy
Education
Finance
Technology
Life Style
Leisure
Culture & Entertainment
Transportation
Society
Heavy Industries
Environment
Government
Services
Why Korea Newswire?
How We Distribute
Services & Pricing
Basic
Standard
Premium
Global
Translation
Press Release Network in Korea
Korean Language
About Us
News
Services
Contact Us
Search
Cancel
Search
Submit Press Release
Latest News
News by Region
Korea
World
News by Industry
Health
Economy
Education
Finance
Technology
Life Style
Leisure
Culture & Entertainment
Transportation
Society
Heavy Industries
Environment
Government
Health News Releases
Today April 21
December 01, 2023 13:10
QPS Holdings, LLC divests its Neuropharmacology Business Unit
Today QPS Holdings, LLC (QPS) a leading drug development Contract Research Organization (CRO), announces an agreement to sell its Neuropharmacology business unit (QPS Neuropharmacology) to Scantox, a
December 01, 2023 11:50
Fujirebio and Sysmex Expand CDMO Partnership into the Field of Neurodegenerative Diseases under Their Immunoassay Collaboration
Fujirebio Holdings, Inc. (President & CEO: Goki Ishikawa) and Sysmex Corporation (President: Kaoru Asano) today announced that they have entered into an agreement to expand their Contract Development
November 30, 2023 15:36
Results From Galderma’s Phase IIIb Trials Demonstrate Rapid and Long-Lasting Effect of RelabotulinumtoxinA on Crow’s Feet and Frown Lines
Galderma announced today topline results from two phase IIIb trials investigating RelabotulinumtoxinA for the treatment of glabellar lines (GL - frown lines) and lateral canthal lines (LCL - crow’s fe
November 30, 2023 15:15
ReValve Solutions Announces Successful First-in-Human with Next Generation TMVR Technology
ReValve Solutions Inc. (ReValve), which has developed a next generation technology for Transcatheter Mitral Valve Replacement (TMVR), announced that an 81-year-old male, with a history of heart failur
November 29, 2023 13:50
Healthcare Leaders Cite Automation, Worker Burnout as Top Drivers of Technology Integrations, MGMA and Laserfiche Study Finds
New research by Medical Group Management Association (MGMA) and Laserfiche (https://www.laserfiche.com/?utm_content=mgma2023&utm_campaign=healthcare) — the leading SaaS provider of intelligent content
November 29, 2023 11:50
Kenvue to Participate in the Morgan Stanley Global Consumer & Retail Conference on December 6, 2023
Kenvue Inc. (NYSE: KVUE) (“Kenvue”), the world’s largest pure-play consumer health company by revenue, today announced the company’s participation in Morgan Stanley’s Global Consumer & Retail Conferen
November 28, 2023 13:20
Kirin iMUSE Immune Care and Healthya Visceral Fat Down will go on sale on Tuesday, November 28!
Kirin Holdings Company, Limited (TOKYO:2503) will launch a dual-care functional food supplement Kirin iMUSE Immuno-Care and Healthya Visceral Fat Down on November 28 (Tuesday). This product is a colla
November 27, 2023 09:00
APR Achieves Consolidated Sales of KRW 122 Billion and Consolidated Operating Profit of KRW 21.7 Billion in Q3 2023
APR Corp. (https://www.apr-in.com/) (APR, CEO: Byunghoon Kim), a global beauty tech company, broke its record-high performance in Q3 2023. APR disclosed on November 14 that it had consolidated sal
November 26, 2023 13:59
Boehringer Ingelheim receives approval for SENVELGO® in Europe: the first oral liquid medication for diabetic cats
Boehringer Ingelheim, a global leader in animal health, has received marketing authorization from the European Commission for SENVELGO® (active ingredient: velagliflozin), marking a significant step f
November 26, 2023 13:36
Japan’s First Discovery*1 on Visceral Fat and Immune Activity in Joint Research by Kirin Holdings and Kao
Kirin Holdings Company, Limited (TOKYO:2503) and Kao Corporation (TOKYO:4452) will participate in the Wakayama Health Promotion Study, a cohort study*2 led by Wakayama Medical University and organized
November 23, 2023 09:50
Boehringer Ingelheim expands immuno-oncology portfolio with the acquisition of bacterial cancer therapy specialist T3 Pharma
Boehringer Ingelheim today announced the acquisition of privately-held T3 Pharmaceuticals AG (“T3 Pharma”), a clinical stage Swiss biotech company, for an amount of up to 450 million CHF. T3 Pharma ha
November 22, 2023 10:40
AstraZeneca launches Evinova, a health-tech business to accelerate innovation across the life sciences sector, the delivery of clinical trials and better health outcomes
AstraZeneca today launches Evinova, set to be a leading provider of digital health solutions to better meet the needs of healthcare professionals, regulators and patients. With long-term backing from
November 21, 2023 16:35
Galderma Reports Record Net Sales of Over 3 B USD for the First Nine Months of 2023 With Strong Growth Momentum Across All Product Categories
Galderma: ·Galderma achieved net sales of 3,009 M USD over the first nine months of 2023, up 8.9% year-on-year on a constant currency basis ·Continued pipeline progress with new milestones reached
November 19, 2023 12:41
MicroVention Celebrates 10-Year Anniversary and Legacy of SOFIA™ Aspiration Catheters; More than 500,000 Procedures Performed Worldwide Across 170 Countries
MicroVention, Inc., a global neurovascular company and wholly owned subsidiary of Terumo Corporation, is celebrating a decade of legacy innovation commemorating the anniversary of SOFIA™ and SOFIA™ Fl
November 19, 2023 11:19
Morinaga Milk’s Probiotic Bifidobacterium breve B-3 Receives Approval of Individual Recognized Registration in South Korea
Morinaga Milk Industry Co., Ltd. (https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.morinagamilk.co.jp%2Fenglish%2F&esheet=53837044&newsitemid=20231116301397&lan=en-US&anchor=Morina
November 17, 2023 17:15
Evidation Selected by Our Future Health as Participant Platform for UK’s Largest Health Research Program
Evidation (https://evidation.com/) — the company creating new ways to measure and improve health in everyday life — today announced a landmark partnership with Our Future Health (https://ourfutureheal
November 17, 2023 11:30
SMK Entered into Capital and Business Alliance Agreement with Canary Speech (US)
SMK Corporation (TOKYO: 6798) (https://www.smk.co.jp/) (President, CEO and COO: Yasumitsu Ikeda, hereinafter referred to as SMK) announced that it has entered into a capital and business alliance agre
November 15, 2023 11:30
Ketamine Clinic in Japan for Inbound Medical Treatment: Nagoya Anesthesia Clinic
Nagoya Anesthesia Clinic (https://nagoyamasui.com/2-2), located in Nagoya City, Aichi Prefecture, Japan, has initiated inbound medical treatment for treatment-resistant depression, other mental disord
November 12, 2023 11:00
GenScript ProBio Signs Viral Vector Manufacturing MOU With Curocell for Next-Generation CAR-T Therapy
On November 10, a global multimodality CDMO, GenScript ProBio and specialized CAR-T therapy firm Curocell signed a strategic partnership MOU for the production of viral vectors necessary for the devel
November 10, 2023 17:40
Takeda Receives U.S. FDA Approval of FRUZAQLA™ for Previously Treated Metastatic Colorectal Cancer
Takeda (TSE:4502/NYSE:TAK (https://www.takeda.com/investors/overview/)) today announced that the U.S. Food and Drug Administration (FDA) has approved FRUZAQLA™ (fruquintinib), an oral targeted therapy
November 10, 2023 12:00
GenScript ProBio Partners With NuclixBio to Pave the Way for South Korea’s First Large-scale Production Process for ‘Circular RNA Therapeutics’
GenScript ProBio, a global multimodality CDMO and NuclixBio, a company developing treatments based on circular RNA, announced on 9th Nov that they have entered into a strategic business agreement to d
November 10, 2023 11:15
Takeda’s ADZYNMA Approved by U.S. FDA as the First and Only Recombinant ADAMTS13 Enzyme Replacement Therapy for the Treatment of Congenital Thrombotic Thrombocytopenic Purpura
Takeda (https://www.takeda.com/) (TSE:4502/NYSE:TAK (https://www.takeda.com/investors/overview/)) today announced that the U.S. Food and Drug Administration (FDA) has approved ADZYNMA (ADAMTS13, recom
November 10, 2023 10:35
Aster Guardians Global Nursing Award 2024 Worth $250,000 to be Held in Bengaluru, India; Application Deadline Extended till 15th December
Aster Guardians Global Nursing Award 2024, an initiative by leading integrated healthcare provider Aster DM Healthcare, has extended the submission deadline to December 15th, 2023. Due to an overwhelm
November 09, 2023 10:15
Confluent Medical Sees Dramatic Improvements Around Supply Chain Visibility and Efficiency
Confluent Medical, a leading materials science, development and manufacturing partner to medical device manufacturers (“OEMs”), has experienced significant improvements to its end-to-end supply chain
November 09, 2023 09:50
Pharma Leader Dr. Holger Zimmermann Joins Lysando's Advisory Board in Pioneering Fight Against Antibiotic-Resistant Bacteria
Lysando, a leading innovator in the fight against antibiotic-resistant bacteria, proudly announces the appointment of Dr. Holger Zimmermann to its Advisory Board. Dr. Zimmermann‘s distinguished career
«
19
20
21
22
23
»
25 per page
25 per page
50 per page
75 per page
100 per page
Distribute Your News to
KOREA
The largest press release distribution network in Korea
34,000 journalists
7,000 media outlets
345 industry channel
80,000 subscribers
Get Started
Global PR service
Reach Your Target
Audience in 160 Countries
powered by
Get Started
News by region
Korea
Overseas
News by industry
Health
Economy
Education
Finance
Technology
Life Style
Leisure
Culture & Entertainment
Transportation
Society
Heavy Industries
Environment
Government
Notice